World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Australia
2026
Award Badge
Medicine
Australia
2023

D-Index & Metrics

Microbiology

D-Index
144
Citations
121932
World Ranking
42
National Ranking
2

Medicine

D-Index
145
Citations
123854
World Ranking
1355
National Ranking
39

Research.com Recognitions

  • 2026 - Research.com Microbiology in Australia Leader Award
  • 2025 - Research.com Microbiology in Australia Leader Award
  • 2023 - Research.com Medicine in Australia Leader Award
  • 2023 - Research.com Microbiology in Australia Leader Award
  • 2022 - Research.com Microbiology in Australia Leader Award
  • 2015 - Fellow of the Australian Academy of Health and Medical Science
  • 2014 - Fellow of the Royal Society of New Zealand

Overview

David L. Paterson is affiliated with the University of Queensland in Australia. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to the subfields of Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology, Pharmacology, and Infectious Diseases.

The scientist's work prominently focuses on topics related to antibiotic resistance and infectious diseases. Key topics in their research include:

  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • Antimicrobial Resistance in Staphylococcus
  • Urinary Tract Infections Management

Among their recent papers are:

  • Antimicrobial Resistance in ESKAPE Pathogens, 2020, Clinical Microbiology Reviews
  • Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial, 2020, The Lancet Infectious Diseases
  • Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study, 2020, The Lancet Infectious Diseases
  • Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study, 2021, The Lancet Infectious Diseases
  • Antibiotics in the clinical pipeline in October 2019, 2020, The Journal of Antibiotics

Frequent co-authors in their research collaborations include:

  • Patrick N. A. Harris
  • Brian M. Forde
  • Joshua S. Davis
  • Adam G. Stewart
  • Jason A. Roberts

The scientist has published extensively in several venues, with notable frequency in:

  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Antimicrobial Chemotherapy
  • JAC-Antimicrobial Resistance

David L. Paterson has been recognized as a Fellow of the Australian Academy of Health and Medical Science in 2015 and a Fellow of the Royal Society of New Zealand in 2014.

Best Publications

  • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

    A-P Magiorakos;A Srinivasan;R B Carey;Y Carmeli

  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

    Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth

  • Extended-spectrum beta-lactamases: a clinical update.

    David L. Paterson;Robert A. Bonomo

  • Acinetobacter baumannii: Emergence of a Successful Pathogen

    Anton Yariv Peleg;Harald Seifert;David L Paterson;David L Paterson

  • Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

    Timothy H. Dellit;Robert C. Owens;John E. McGowan;Dale N. Gerding

  • Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

    David L. Paterson;Susan Swindells;Jeffrey Mohr;Michelle Brester

  • Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

    Karthikeyan K. Kumarasamy;Mark Alexander Howard Toleman;Timothy Rutland Walsh;Jay Bagaria

  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber

  • Antimicrobial resistance in ESKAPE pathogens

    David M. P. De Oliveira;Brian M. Forde;Timothy J. Kidd;Patrick N. A. Harris

  • Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

    Jian Li;Roger Leigh Nation;John D Turnidge;Robert W Milne

  • Resistance in Gram-Negative Bacteria: Enterobacteriaceae

    David L. Paterson

  • Critical care services and 2009 H1N1 influenza in australia and new zealand.

    Steven A R Webb;Ville Yrjo Olavi Pettila;Ian M Seppelt;Rinaldo Bellomo

  • Peritoneal dialysis-related infections recommendations: 2005 update

    Beth Piraino;George R. Bailie;Judith Bernardini;Elisabeth Boeschoten

  • Predictors of Mortality in Staphylococcus aureus Bacteremia

    Sebastian J. van Hal;Slade O. Jensen;Slade O. Jensen;Vikram L. Vaska;Björn A. Espedido;Björn A. Espedido

  • Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

    Samira Garonzik;Jian Li;Jian Li;Visanu Thamlikitkul;David Paterson

  • Distribution of Legionella Species and Serogroups Isolated by Culture in Patients with Sporadic Community-Acquired Legionellosis: An International Collaborative Survey

    Victor L. Yu;Joseph F. Plouffe;Maddalena Castellani Pastoris;Janet E. Stout

  • International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections

    David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunlta Mohapatra

  • Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

    Benjamin A. Rogers;Hanna E. Sidjabat;David L. Paterson

  • Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial

    Patrick N. A. Harris;Patrick N. A. Harris;Patrick N. A. Harris;Paul A. Tambyah;David C. Lye;David C. Lye;David C. Lye;Yin Mo

  • Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity

    ML Avent;B Rogers;Allen Cheng;Allen Cheng;David Paterson

  • Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (vol 133, pg 21, 2000)

    DL Paterson;S Swindells;J Mohr;M Brester

Frequent Co-Authors

Jeffrey Lipman
Jeffrey Lipman University of Queensland
Jason A. Roberts
Jason A. Roberts University of Queensland
Yohei Doi
Yohei Doi University of Pittsburgh
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Nicholas Graves
Nicholas Graves Queensland University of Technology
Nina Singh
Nina Singh University of Pittsburgh
Scott A. Beatson
Scott A. Beatson University of Queensland
Shahid Husain
Shahid Husain University Health Network
Mark A. Schembri
Mark A. Schembri University of Queensland
Graeme R. Nimmo
Graeme R. Nimmo Griffith University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options. Beyond traditional lab roles, students often explore related fields that combine science with practical application. For example, those interested in healthcare may consider becoming a functional medicine nurse, blending clinical care with holistic health approaches.

Online education has also made it easier for individuals from various backgrounds to advance their careers. If you have a criminal record, you might wonder what options are available. Resources like what can a felon go to college for provide valuable guidance on accessible degrees and career paths that can still lead to rewarding opportunities.

Additionally, some professionals complement microbiology knowledge with certifications in medical coding. Understanding the professional coder certification can open alternative roles in healthcare administration and support essential medical research documentation.

Lastly, for those passionate about child health and development, careers like a child life specialist salary highlight how specialized scientific knowledge can translate into impactful work that supports children and families in medical settings.

Best Scientists Citing David L. Paterson

Trending Scientists

Recently Published Articles